TD Asset Management’s GeneDx Holdings Warrant WGSWW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-34,884
| Closed | -$101 | – | 1263 |
|
|
2026
Q2 | $101 | Hold |
34,884
| – | – | ﹤0.01% | 1216 |
|
|
2026
Q1 | $279 | Hold |
34,884
| – | – | ﹤0.01% | 1230 |
|
|
2025
Q4 | $1.65K | Hold |
34,884
| – | – | ﹤0.01% | 1232 |
|
|
2025
Q3 | $3.82K | Hold |
34,884
| – | – | ﹤0.01% | 1234 |
|
|
2025
Q2 | $2.3K | Hold |
34,884
| – | – | ﹤0.01% | 1192 |
|
|
2025
Q1 | $7.33K | Hold |
34,884
| – | – | ﹤0.01% | 1214 |
|
|
2024
Q4 | $5.58K | Hold |
34,884
| – | – | ﹤0.01% | 1241 |
|
|
2024
Q3 | $2.41K | Hold |
34,884
| – | – | ﹤0.01% | 1383 |
|
|
2024
Q2 | $1.04K | Hold |
34,884
| – | – | ﹤0.01% | 1360 |
|
|
2024
Q1 | $1.92K | Hold |
34,884
| – | – | ﹤0.01% | 1379 |
|
|
2023
Q4 | $415 | Hold |
34,884
| – | – | ﹤0.01% | 1388 |
|
|
2023
Q3 | $1.04K | Buy |
34,884
+17,442
| +100% | +$485 | ﹤0.01% | 1407 |
|
|
2023
Q2 | $124 | Hold |
17,442
| – | – | ﹤0.01% | 1410 |
|
|
2023
Q1 | $323 | Hold |
17,442
| – | – | ﹤0.01% | 1427 |
|
|
2022
Q4 | $331 | Hold |
17,442
| – | – | ﹤0.01% | 1444 |
|
|
2022
Q3 | $3K | Hold |
17,442
| – | – | ﹤0.01% | 1470 |
|
|
2022
Q2 | $6K | Hold |
17,442
| – | – | ﹤0.01% | 1452 |
|
|
2022
Q1 | $12K | Hold |
17,442
| – | – | ﹤0.01% | 1478 |
|
|
2021
Q4 | $17K | Hold |
17,442
| – | – | ﹤0.01% | 1489 |
|
|
2021
Q3 | $37K | Buy |
+17,442
| New | +$57.3K | ﹤0.01% | 1515 |
|
TD Asset Management's WGSWW Position: Q3 2026 in Review
TD Asset Management sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2026, closing a stake of 34,884 shares — an estimated $101 sold.
TD Asset Management first reported a position in WGSWW in Q3 2021 and held it in 20 quarters. The position peaked at $37K in Q3 2021. 0 funds tracked by Wall St. Rank hold WGSWW as of Q3 2026.
- TD Asset Management reported no remaining GeneDx Holdings Warrant position as of Q3 2026 after selling out during the quarter.
- TD Asset Management sold 34,884 GeneDx Holdings Warrant shares in Q3 2026, an estimated $101.
- TD Asset Management first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 20 quarters.
- TD Asset Management's GeneDx Holdings Warrant position peaked at $37K in Q3 2021.
- 0 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2026.
Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.